Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism

Author： Ruchat Stephanie-May Vohl Marie-Claude Weisnagel S. John Rankinen Tuomo Bouchard Claude Pérusse Louis

ISSN： 0785-3890

Source： Annals of Medicine, Vol.42, Iss.3, 2010-04, pp. : 196-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans

By Wang Zhen

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 220-229

Informa Healthcare

Access to resources Recommend Favorite

Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 2, 2015-02 ,pp. : 219-227

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?

By Moorman Patricia G

Personalized Medicine, Vol. 9, Iss. 6, 2012-08 ,pp. : 565-567

Future Medicine

Access to resources Recommend Favorite

Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose

By Liu Jian Joshi Divya Sempos Christopher T.

Applied Physiology, Nutrition, and Metabolism, Vol. 34, Iss. 2, 2009-04 ,pp. : 136-142

NRC Research Press

Access to resources Recommend Favorite

Geographic differences in the associations between impaired glucose regulation and cardiovascular risk factors among young adults

DIABETIC MEDICINE, Vol. 32, Iss. 4, 2015-04 ,pp. : 497-504

John Wiley & Sons Inc

Access to resources Recommend Favorite